Kyriakoudi Anna, Rovina Nikoletta, Koltsida Ourania, Kostakou Eirini, Konstantelou Elissavet, Kardara Matina, Kompoti Maria, Palamidas Anastasios, Kaltsakas Georgios, Koutsoukou Antonia
1st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens and "Sotiria" Chest Disease Hospital, 11527 Athens, Greece.
1st Department of Critical Care Medicine & Pulmonary Services, National and Kapodistrian University of Athens, Medical School, Evangelismos Hospital, 10676 Athens, Greece.
Diagnostics (Basel). 2021 Dec 31;12(1):92. doi: 10.3390/diagnostics12010092.
Septic patients undergoing mechanical ventilation (MV) often experience difficulty in weaning. Th aim of this study was to determine whether inflammatory biomarkers of sepsis could be indicative of the failure or success of spontaneous breathing trial (SBT) in these patients.
Sixty-five patients on MV (42 septic and 23 intubated for other reasons) fulfilling the criteria for SBT were included in the study. Blood samples were collected right before, at the end of (30 min) and 24 h after the SBT. Serum inflammatory mediators associated with sepsis (IL-18, IL-18BP, TNF) were determined and correlated with the outcome of SBT.
A successful SBT was achieved in 45 patients (69.2%). Septic patients had a higher percentage of SBT failure as compared to non-septic patients (85% vs. 15%, = 0.026), with an odds ratio for failing 4.5 times (OR = 4.5 95%CI: 1.16-17.68, 0.022). IL-18 levels and the relative mRNA expression in serum were significantly higher in septic as compared to non-septic patients ( < 0.05). Sepsis was independently associated with higher serum IL-18 and TNF levels in two time-point GEE models (53-723, = 0.023 and 0.3-64, = 0.048, respectively). IL-18BP displayed independent negative association with rapid shallow breathing index (RSBI) (95% CI: -17.6 to -4, = 0.002).
Sustained increased levels of IL-18 and IL-18BP, acknowledged markers of sepsis, were found to be indicative of SBT failure in patients recovering from sepsis. Our results show that, although subclinical, remaining septic inflammation that sustaines for a long time complicates the weaning procedure. Biomarkers for the estimation of the septic burden and the right time for weaning are needed.
接受机械通气(MV)的脓毒症患者常常在撤机方面存在困难。本研究的目的是确定脓毒症的炎症生物标志物是否可指示这些患者自主呼吸试验(SBT)的失败或成功。
65例符合SBT标准的接受MV治疗的患者(42例脓毒症患者和23例因其他原因插管的患者)纳入本研究。在SBT前、结束时(30分钟)和结束后24小时采集血样。测定与脓毒症相关的血清炎症介质(IL-18、IL-18BP、TNF),并将其与SBT的结果进行关联分析。
45例患者(69.2%)成功完成SBT。与非脓毒症患者相比,脓毒症患者SBT失败的比例更高(85%对15%,P = 0.026),失败的优势比为4.5倍(OR = 4.5,95%CI:1.16 - 17.68,P = 0.022)。与非脓毒症患者相比,脓毒症患者血清中的IL-18水平及其相对mRNA表达显著更高(P < 0.05)。在两个时间点的广义估计方程(GEE)模型中,脓毒症分别与更高的血清IL-18和TNF水平独立相关(β = 53 - 723,P = 0.023和β = 0.3 - 64,P = 0.048)。IL-18BP与快速浅呼吸指数(RSBI)呈独立负相关(95%CI:-17.6至-4,P = 0.002)。
脓毒症公认的标志物IL-18和IL-18BP持续升高的水平被发现可指示脓毒症康复患者SBT失败。我们的结果表明,尽管是亚临床的,但长期持续存在的残余脓毒症炎症会使撤机过程复杂化。需要用于评估脓毒症负担和确定撤机合适时机的生物标志物。